- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01935284
Evaluation of Blood Gas Syringes (Analyze ABS)
August 30, 2013 updated by: Smiths Medical, ASD, Inc.
Post-Market Study Evaluating Analyzer Readings of Multiple Arterial Blood Gas Syringes
To assess the interchangeability and agreement between measurements from three blood gas syringes for the collection of blood for the analysis of multiple analytes as measured by differing manufacturers' multi-parameter analyzers.
Study Overview
Status
Completed
Conditions
Detailed Description
This is a prospective, randomized, post-market study using fresh blood for analysis that is obtained from healthy subject volunteers.
Trained phlebotomists will collect blood samples from subjects after confirmation of eligibility criteria.
Blood samples will be drawn to fill all study syringe types in a randomized order.
Each syringe type will be drawn per subject to analyze each of the available blood parameters in duplicate using three different multi-parameter analyzers.
The analytes tested will vary per analyzer capabilities.
All blood draws and analyte testing will be performed at an independent laboratory.
The study is to confirm that all of the syringes tested provide consistent readings when analyzed using the most common multi-parameter analyzers used in hospital laboratories.
Study Type
Observational
Enrollment (Actual)
26
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Devens, Massachusetts, United States, 01434
- Bionostics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older
- Willing and able to independently sign an English Informed Consent
- Have adequate veins for sampling blood from both right and left upper extremities
Exclusion Criteria:
- Currently taking anti-coagulation medication
- Have a known bloodborne disease or bleeding tendency
- Have a known fear or adverse reaction to needles or blood
- Women who are pregnant or nursing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Healthy Volunteers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences in analyte values obtained from three different blood gas syringes for each analyzer tested
Time Frame: Blood analysis within 30 minutes of draw
|
For each of the analytes that are tested, the analyte values from each of the three (3) syringe types tested will be compared for each of the three (3) multi-parameter analyzers.
Average values for each analyte per patient, syringe and analyzer will be used for the comparison of syringes for each analyzer.
|
Blood analysis within 30 minutes of draw
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Lisa Cifaldi, BS, RRT, Smiths Medical
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Actual)
June 1, 2013
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
June 26, 2013
First Submitted That Met QC Criteria
August 30, 2013
First Posted (Estimate)
September 5, 2013
Study Record Updates
Last Update Posted (Estimate)
September 5, 2013
Last Update Submitted That Met QC Criteria
August 30, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- Analyze ABS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Gas Analyte Values
-
University Hospital, GrenobleCompletedBlood Gas Monitoring, TranscutaneousFrance
-
University Hospital, Basel, SwitzerlandSenTec AG, Ringstrasse 39, CH-4106 TherwilTerminated
-
Mahidol UniversityCompleted
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedArterial Blood Gas AnalysisTurkey (Türkiye)
-
Umeå UniversityCompletedBlood Gas Monitoring, TranscutaneousSweden
-
Haydarpasa Numune Training and Research HospitalActive, not recruitingBlood Gas Analysis | Topical AnalgesiaTurkey
-
Hadassah Medical OrganizationWithdrawnBlood Gas Monitoring, TranscutaneousIsrael
-
Cemile Nida KayışCompletedArterial Blood Gas Analysis EducationTurkey (Türkiye)
-
Xijing HospitalUnknownDisorder of Blood Gas | Bypass ComplicationsChina
-
University of PatrasCompletedInfluence of PRU Values on Primary OutcomeGreece